Differences in Long COVID severity by duration of illness, symptom evolution, and vaccination: a longitudinal cohort study from the INSPIRE group
- PMID: 40040820
- PMCID: PMC11875141
- DOI: 10.1016/j.lana.2025.101026
Differences in Long COVID severity by duration of illness, symptom evolution, and vaccination: a longitudinal cohort study from the INSPIRE group
Abstract
Background: Although short-term outcomes of Long COVID have been described, longer-term physical and mental health outcomes of Long COVID are less well-established. This study sought to assess differences in long-term physical and mental health outcomes extending up to three years among those with current, resolved, and no Long COVID, as well as duration of Long COVID and vaccination status.
Methods: This was a prospective, multisite, study of participants with SARS-CoV-2 infection from 12/7/2020-8/29/2022, with data collected through 4/2/2024. Surveys included validated tools for physical and mental health. Data were analyzed by Long COVID status (never-had, resolved, current), Long COVID duration and vaccination status.
Findings: Of 3663 participants, 2604 (71.1%) never had Long COVID, 994 (27.1%) reported current Long COVID, and 65 (1.8%) reported resolved Long COVID. Compared to never having Long COVID, current Long COVID had lower/worse scores for Patient-Reported Outcomes Measurement Information System (PROMIS) version 29 Physical (7.8; 95% confidence interval [CI] 7.3-8.3) and Mental Health (9.4; 95% CI 8.8-10.1) and higher likelihood of moderate-to-high stress (adjusted odds ratio [aOR]: 2.0; 95% CI 1.6-2.4), moderate-to-high loneliness (aOR: 1.6; 95% CI 1.4-2.0), moderate-to-severe fatigue (aOR: 3.0; 95% CI 2.5-3.7), insufficient activity (aOR for Speedy Nutrition and Physical Activity Assessment ≤4: 0.6; 95% CI 0.5-0.7; aOR for Exercise Vital Sign ≤150 min/week: 0.7, 95% CI 0.6-1.0), and worse dyspnea (aOR: 5.0; 95% CI 4.3-5.8). Resolved Long COVID had lower scores for PROMIS Physical by 2.0 (95% CI 0.2-3.8) and Mental Health by 2.3 (95% CI 0.2-4.4) than the never-had-Long COVID cohort. Number of COVID-19 vaccinations was associated with better outcomes across all measures.
Interpretation: Among participants followed up to 3 years after initial infection, those with current Long COVID had worse physical and mental health outcomes. The majority of those with Long COVID did not resolve, with less than 2% having resolved Long COVID. The resolved Long COVID cohort had moderately worse physical and mental health compared with those never-having-Long COVID. COVID-19 vaccination was associated with better outcomes.
Funding: Centers for Disease Control and Prevention.
Keywords: Long COVID; Mental health; PROMIS; Physical health; SARS-CoV-2.
© 2025 The Author(s).
Conflict of interest statement
Michael Gottlieb reports funding from Society for Academic Emergency Medicine Foundation Emerging Infectious Disease and Preparedness Grant. Nicole L. Gentile reports funding from Improving Access to Multidisciplinary Care for Patients with Long COVID (AHRQ, U18 HS29905-01), Pain Relief with Integrative Medicine (PRIMe)?: Feasibility Trial of Acupuncture for Long COVID (NCCIH, R34AT012679-01), Interaction between SARS-CoV-2 Infection and Ancestral genomic Variations in the Risk of Alzheimer's Disease and Related Disorders (ISAVRAD) (NIA, U19 AG076581-01A1), Post-Acute Sequelae of SARS-CoV-2 (PASC): Analysis of Autoantibody Abnormalities and Impact of Pain on Quality of Life and Function Royalty Research Fund – University of Washington. Rachel E. Geyer reports funding from Improving Access to Multidisciplinary Care for Patients with Long COVID (AHRQ, U18 HS29905-01), Pain Relief with Integrative Medicine (PRIMe)?: Feasibility Trial of Acupuncture for Long COVID (NCCIH, R34AT012679-01), Post-Acute Sequelae of SARS-CoV-2 (PASC): Analysis of Autoantibody Abnormalities and Impact of Pain on Quality of Life and Function Royalty Research Fund – University of Washington UW Core Center for Clinical Research (CCCR) of Musculoskeletal Conditions (NIH, P30 AR072572-08). Joann G Elmore serves as Editor-In-Chief for adult general medicine topics at UpToDate. Ralph C Wang reports funding from the SAEM Foundation Emerging Infectious Disease and Preparedness Grant. Kristin Rising reports funding from the Preventing Emerging Infections Through Vaccine Effectiveness Testing (Project PREVENT) II (CDC U01CK00048), PROmotion of COVid-19 VA(X)ccination in the Emergency Department (PROCOVAXED; NIH 1R01AI66967), and the COVID-19 Mobile Vaccination Program – Philadelphia Department of Public Health. Arjun K Venkatesh reports funding from Society for Academic Emergency Medicine Foundation Emerging Infectious Disease and Preparedness Grant. All authors received institutional funding from the Centers for Disease Control and Prevention (75D30120C08008) for the conduct of this study.
Figures








References
-
- World Health Organization WHO COVID-19 dashboard. https://data.who.int/dashboards/covid19/cases
-
- World Health Organization Post COVID-19 condition (long COVID) https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-cond...
-
- Centers for Disease Control and Prevention Clinical overview of long COVID. https://www.cdc.gov/covid/hcp/clinical-overview/index.html
-
- National Institute for Health and Care Excellence COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline [NG188] https://www.nice.org.uk/guidance/NG188 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous